Who Paid My Doc
Wolf Heberlein
Interventional Pain Medicine Jonesboro, AR Medical Doctor
NPI 1922121698 CMS profile 959264
3800 E Johnson Ave, Ste E, Jonesboro, AR 72401
General payments
$4,587
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Wolf Heberlein of Jonesboro, AR is reported in the CMS Open Payments database as having received $4,587 across 100 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 53rd percentile of Interventional Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $504 | 6 | |
| 2024 | General | $1,228 | 16 | |
| 2023 | General | $156 | 4 | |
| 2022 | General | $901 | 12 | |
| 2021 | General | $844 | 15 | |
| 2020 | General | $379 | 16 | |
| 2019 | General | $575 | 31 |
Beside peers
- Wolf Heberlein
- Interventional Pain Medicine median
- Middle half of Interventional Pain Medicine
- National median
In program year 2025, general payments to Wolf Heberlein were reported at $504. Among 1,891 Interventional Pain Medicine profiles paid that year, the median was $657 and the middle half received between $184 and $1,753.
Show as a table
| Year | Wolf Heberlein | Interventional Pain Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $575 | $684 | $216–$2,079 | $163 |
| 2020 | $379 | $382 | $122–$1,109 | $114 |
| 2021 | $844 | $552 | $167–$1,554 | $132 |
| 2022 | $901 | $605 | $187–$1,924 | $149 |
| 2023 | $156 | $671 | $195–$1,915 | $160 |
| 2024 | $1,228 | $684 | $206–$1,837 | $164 |
| 2025 | $504 | $657 | $184–$1,753 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 51 billing codesPaid by Medicare
$416,046
Medicare patients
529
Services billed
9,482
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 75% | |
| Diabetes | 32% | |
| Ischemic heart disease | 31% | |
| Depression | 31% | |
| Chronic kidney disease | 21% | |
| Atrial fibrillation | 20% | |
| Osteoporosis | 20% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 | Office | 438 | 6,465 | $4,942 |
| Injection, cefazolin sodium, 500 mg J0690 | Office | 12 | 24 | $15 |
| Infusion, normal saline solution, 250 cc J7050 | Office | 12 | 12 | $6 |
| Injection, dexamethasone sodium phosphate, 1 mg J1100 | Office | 12 | 68 | $6 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Payments and prescribing
3 products · payments 2024Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.
| Product | Paid by | Related payments | Part D claims | Part B services |
|---|---|---|---|---|
| EVENITY |
|
$30 | — | — |
| Qutenza |
|
$29 | — | — |
| Prolia |
|
$9 | — | — |
A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.
Records
100 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Interventional Pain Medicine in Arkansas
Sameer Jain
Interventional Pain Medicine · Bryant, AR
Ryan Krafft
Interventional Pain Medicine · Mountain Home, AR
Robert Cannon
Interventional Pain Medicine · Fayetteville, AR
Amir Qureshi
Interventional Pain Medicine · Little Rock, AR
Brett Whatcott
Interventional Pain Medicine · Fort Smith, AR
Mohammad Eldeeb
Interventional Pain Medicine · Fort Smith, AR
Related records
Interventional Pain Medicine in Arkansas
Practitioners in the same specialty and state, ranked by reported value.
All Interventional Pain Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Arkansas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.